Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EMRESERVA A Program to Enhace Cognitive Reserve in Patients With Multiple Scleorisis

NCT05546424 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as lead sponsor.

NCT NCT05546424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05546424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EMRESERVA A Program to Enhace Cognitive Reserve in Patients With Multiple Scleorisis
Lead sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase
Observational
Overall status
Completed
Start date
May 19, 2022
Completion date
November 30, 2023
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive change